Life Sciences

Northeastern University is using revenue from a $378.5 million tax-exempt bond to build a 340,000 square foot science and engineering complex in Boston's Fenway neighborhood.

“Grace” Jinliu Wang, who on Nov. 7 was selected by WPI to be its 17th president, believes in and embodies this concept of combining theory and practice to fuel innovation and to apply that innovation to have maximum impact on the world.

Frank Mathias will step down as the CEO of Rentschler Biopharma SE, which has its American base of operations in Milford, and will join Oxford Biomedica plc in England in March.

Rentschler Biopharma has appointed Christiane Bardroff as the company’s next chief operating officer, whose responsibilities include overseeing construction work at its Milford location.

Marlborough-based medical technology company Hologic Inc. has been awarded a $19-million contract for further research and development of the company’s disease testing systems.

Sunovion Pharmaceuticals of Marlborough will lay off 360 of its 1,200 employees, effective Jan. 13.

A biomanufacturing facility at 92 Crowley Drive in Marlborough was sold by San Diego biotech National Resilience, Inc. to Canadian real estate giant Oxford Properties Group of Toronto on Thursday.

Biopharmaceutical manufacturer Rentschler Biopharma, which counts Milford as its main U.S. location, hired Tobias Glueck to lead its global human resources team as its new senior vice president of the department.

A Holyoke developer has proposed Gateway Park III, a five-story, 125,000-square-foot laboratory and office building in Worcester.

PIC Therapeutics Inc. of Natick completed a $35-million round of financing fund developments to fight drug-resistant breast cancer.